Intermittent Versus Continuous Medication in the Treatment of HIV

PHASE4CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

November 30, 1999

Study Completion Date

November 30, 2004

Conditions
HIV Infection
Interventions
DRUG

HAART

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001967 - Intermittent Versus Continuous Medication in the Treatment of HIV | Biotech Hunter | Biotech Hunter